Abstract
Binge eating disorder (BED) has limited therapeutic options. Repetitive transcranial magnetic stimulation (rTMS) is a modulation technique of cortical excitability that has shown good results in treating certain psychiatric disorders by correcting dysfunctional cortical regions. We hypothesize that rTMS could be an alternative therapy for BED through potential modulation action on frontostriatal abnormalities and dopaminergic pathways noted by neuroimaging. We report the case of a young woman presenting refractory BED and comorbid depression treated with 20 sessions of rTMS for 30 minutes over the left dorsolateral prefrontal cortex at 10 Hz for about a month (2400 stimuli per day). She answered two self-report questionnaires, the Binge Eating Scale (BES) and the Beck Depression Inventory (BDI). Before rTMS treatment, the BES score was 38, and the BDI score was 42. Three days after rTMS treatment, the BES score was 27 and the BDI score was 23, and the patient referred to no binge eating episodes for that week. Therefore, rTMS could offer a new option of treatment for BED and comorbid depression.
Keywords: Binge eating disorder, depression, dopamine, frontostriatal pathways, obesity, repetitive transcranial magnetic stimulation.
CNS & Neurological Disorders - Drug Targets
Title:High-Frequency rTMS to Treat Refractory Binge Eating Disorder and Comorbid Depression: A Case Report
Volume: 13 Issue: 5
Author(s): Tathiana Pires Baczynski, Carolina Hanna de Aquino Chaim, Bruno Palazzo Nazar, Mauro Giovanni Carta, Oscar Arias-Carrion, Adriana Cardoso Silva, Sergio Machado and Antonio Egidio Nardi
Affiliation:
Keywords: Binge eating disorder, depression, dopamine, frontostriatal pathways, obesity, repetitive transcranial magnetic stimulation.
Abstract: Binge eating disorder (BED) has limited therapeutic options. Repetitive transcranial magnetic stimulation (rTMS) is a modulation technique of cortical excitability that has shown good results in treating certain psychiatric disorders by correcting dysfunctional cortical regions. We hypothesize that rTMS could be an alternative therapy for BED through potential modulation action on frontostriatal abnormalities and dopaminergic pathways noted by neuroimaging. We report the case of a young woman presenting refractory BED and comorbid depression treated with 20 sessions of rTMS for 30 minutes over the left dorsolateral prefrontal cortex at 10 Hz for about a month (2400 stimuli per day). She answered two self-report questionnaires, the Binge Eating Scale (BES) and the Beck Depression Inventory (BDI). Before rTMS treatment, the BES score was 38, and the BDI score was 42. Three days after rTMS treatment, the BES score was 27 and the BDI score was 23, and the patient referred to no binge eating episodes for that week. Therefore, rTMS could offer a new option of treatment for BED and comorbid depression.
Export Options
About this article
Cite this article as:
Baczynski Pires Tathiana, Chaim Hanna de Aquino Carolina, Nazar Palazzo Bruno, Carta Giovanni Mauro, Arias-Carrion Oscar, Silva Cardoso Adriana, Machado Sergio and Nardi Egidio Antonio, High-Frequency rTMS to Treat Refractory Binge Eating Disorder and Comorbid Depression: A Case Report, CNS & Neurological Disorders - Drug Targets 2014; 13 (5) . https://dx.doi.org/10.2174/1871527313666140307154823
DOI https://dx.doi.org/10.2174/1871527313666140307154823 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Insights in Developmental Coordination Disorder
Current Pediatric Reviews Progress of Biosensors Based on Cholinesterase Inhibition
Current Medicinal Chemistry Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews Design, Synthesis, <i>In Silico</i> and <i>In Vitro</i> Evaluation of Novel Pyrimidine Derivatives as EGFR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Vitamin D, Sunlight and Cancer Connection
Anti-Cancer Agents in Medicinal Chemistry Quadruplex DNA: A Promising Drug Target for the Medicinal Inorganic Chemist
Current Topics in Medicinal Chemistry Transition Metal Salt-Mediated Radical Reactions of [60]Fullerene
Current Organic Chemistry OMEGA-3 Interventions in Alcohol Dependence and Related Outcomes: A Systematic Review and Propositions
Current Neuropharmacology Structure-Specific Ligand Recognition of Multistranded DNA Structures
Current Topics in Medicinal Chemistry Beclin 1 Biology and its Role in Heart Disease
Current Cardiology Reviews Effects of Tetrahydroxystilbene Glucoside on Liver P450 Enzym e Expressions in Lipopolysaccharide-induced Dopamine Neuronal Dama ge Rats
Letters in Drug Design & Discovery Hospital-Based Tobacco Interventions in Pediatric Settings
Current Pediatric Reviews Antioxidants as a Potential Therapy Against Age-Related Neurodegenerative Diseases: Amyloid Beta Toxicity and Alzheimers Disease
Current Pharmaceutical Design Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System
CNS & Neurological Disorders - Drug Targets Expanding our Understanding of Polyglutamine Disease Through Transgenic Mice
Current Genomics Soft Computing Techniques for the Protein Folding Problem on High Performance Computing Architectures
Current Drug Targets Axonopathy Likely Initiates Neuropathological Processes Via a Mechanism of Axonal Leakage in Alzheimer's Mouse Models
Current Molecular Medicine Investigating the In Vivo Expression Patterns of miR-7 microRNA Family Members in the Adult Mouse Brain
MicroRNA Endogenous Repair System of Oxidative Damage of DNA
Current Chemical Biology Milk Fat Globule Epidermal Growth Factor VIII Signaling in Arterial Wall Remodeling
Current Vascular Pharmacology